Elevation Pharmaceuticals Inc

Corporate Profile

Registration country: 
United States
Overview 
Founded in 2008, Elevation Pharmaceuticals is developing a pipeline of improved aerosol drug products for COPD patients. Our founding team has a successful track record starting companies and building dedicated teams to develop new drug products that improve patients' lives. At Elevation, we have a disciplined approach to strategic decision-making that helps us stay focused on the path with the highest probability of success. We are executing our drug development plans with passion, integrity, and a high sense of urgency in order to meet the needs and expectations of our stakeholders -- employees, investors, partners, and patients.

Investors

Investor Profile Amount Stage Date
Canaan Partners Venture capital firm with a focus on early stage technology and healthcare companies Sep 2011
Canaan Partners Venture capital firm with a focus on early stage technology and healthcare companies USD Series B Jan 2012
Care Capital LLC USD Series A Sep 2011
Care Capital LLC USD Series B Jan 2012
Mesa Verde Venture Partners USD Series A Sep 2011
Mesa Verde Venture Partners USD Series B Jan 2012
Novo Ventures (US) Inc USD Series B Jan 2012
TPG Biotechnology Partners LP USD Series B Jan 2012
TPG Capital LP One of the world's largest private equity firms USD Series A Sep 2011
TPG Growth

Current employees

No current employees available

add an employee

RECORD ID: 111321